Health
COVID-19 rapid antibody test receives CE mark and mass production begins – News-Medical.Net
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium (UK-RTC), has received its CE mark. This means it is approved for professional use in the UK and EU.
This milestone means the rapid test, for detection of IgG antibodies to the SARS-CoV-2 virus (COVID-19) is now available for distribution for professional use. It will be mass produced and tests will be rolled out from the end of August. The test can be administere…
-
Noosa News19 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News21 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News17 hours agoFranz Ferdinand: Australian Tour 2025
-
Business17 hours agoHow these 5 ASX 200 stocks are smashing the benchmark this week